Chikungunya Disease, a kind of mosquito infectious disease, might lead to chronic weakness, arthritis, and death in serious cases. Due to climate change, Chikungunya disease increases amongst those families affected by tropical mosquitos. Presently, the disease might take place in the northern areas, New York, and the south of Sydney. With increasing severity of morbidity, increase of outbreaks, and extensive geographical distribution of virus, Chikungunya vaccine is in short supply. Based on its dedicated SCV victor system, Sementis Ltd. is developing prophylactic vaccine for Chikungunya-stricken areas.